Patents by Inventor Reese S. Terry, Jr.
Reese S. Terry, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8874218Abstract: A method of providing an electrical signal to a cranial nerve of a patient for treating a medical condition, including providing an electrical signal generator, coupling at least a first electrode to a cranial nerve of the patient and to the electrical signal generator, generating an electrical signal with the electrical signal generator, and applying the electrical signal to the cranial nerve, using the at least a first electrode, for a duration less than a cardiac period of the patient and during the cardiac period of the patient. In addition, an implantable medical device capable of implementing the method is disclosed.Type: GrantFiled: April 23, 2013Date of Patent: October 28, 2014Assignee: Cyberonics, Inc.Inventor: Reese S. Terry, Jr.
-
Publication number: 20140200622Abstract: According to some embodiments, the present invention provides a device, system, and methods for treating a plurality of conditions in a patient, where the device, system, and methods provide a stimulation signal for each condition, wherein each stimulation signal has one or more of polarity, direction, and pulse patterns selected for the respective condition. According to some embodiments, the conditions comprise congestive heart failure and stroke.Type: ApplicationFiled: January 17, 2013Publication date: July 17, 2014Applicant: Trifectas Medical Corp.Inventors: Reese S. Terry, JR., Ingela Danielsson
-
Patent number: 8700163Abstract: A method of treating a patient with at least one substance addiction, which comprises directly stimulating a cranial nerve, such as the vagus nerve, of a patient with an electrical pulse signal defined by a plurality of parameters to provide a therapy regimen for alleviating a symptom associated with the substance addiction.Type: GrantFiled: April 29, 2005Date of Patent: April 15, 2014Assignees: Cyberonics, Inc.Inventors: Reese S. Terry, Jr., Jacob Zabara
-
Patent number: 8457747Abstract: We disclose a method of providing an electrical signal to a cranial nerve of a patient for treating a medical condition, comprising providing an electrical signal generator, coupling at least a first electrode to a cranial nerve of the patient and to the electrical signal generator, generating an electrical signal with the electrical signal generator, and applying the electrical signal to the cranial nerve, using the at least a first electrode, for a duration less than a cardiac period of the patient and during the cardiac period of the patient. We also disclose an implantable medical device capable of implementing the method.Type: GrantFiled: October 20, 2008Date of Patent: June 4, 2013Assignee: Cyberonics, Inc.Inventor: Reese S. Terry, Jr.
-
Publication number: 20100100151Abstract: We disclose a method of providing an electrical signal to a cranial nerve of a patient for treating a medical condition, comprising providing an electrical signal generator, coupling at least a first electrode to a cranial nerve of the patient and to the electrical signal generator, generating an electrical signal with the electrical signal generator, and applying the electrical signal to the cranial nerve, using the at least a first electrode, for a duration less than a cardiac period of the patient and during the cardiac period of the patient. We also disclose an implantable medical device capable of implementing the method.Type: ApplicationFiled: October 20, 2008Publication date: April 22, 2010Inventor: Reese S. Terry,, JR.
-
Patent number: 6622038Abstract: A method for treating patients with movement disorders includes unilaterally or bilaterally stimulating one or both of the left and right branches of a patient's vagus nerve directly or indirectly with an electrical pulse signal generated by an implantable neurostimulator with at least one operatively coupled nerve electrode to apply the pulse signal to the selected nerve branch at a location in the vicinity of the patient's diaphragm, either slightly above or slightly below the diaphragm. A device for performing the method includes a government approved implantable neurostimulator which is programmable to enable physician programming of electrical and timing parameters of the pulse signal, to generate the desired therapy regimen for alleviating the disorder by application of the therapeutic electrical stimulation signal to a selected nerve. Automatic detection or patient sensing of a symptom of the disorder may be utilized for activating the device.Type: GrantFiled: July 28, 2001Date of Patent: September 16, 2003Assignee: Cyberonics, Inc.Inventors: Burke T. Barrett, Reese S. Terry, Jr.
-
Patent number: 6622041Abstract: A device for treating patients suffering from congestive heart failure includes an implantable neurostimulator for stimulating the patient's vagus nerve at or above the cardiac branch with an electrical pulse waveform at a stimulating rate sufficient to maintain the patient's heart beat at a rate well below the patient's normal resting heart rate, thereby allowing rest and recovery of the heart muscle, to increase in coronary blood flow, and/or growth of coronary capillaries. A metabolic need sensor detects the patient's current physical state and concomitantly supplies a control signal to the neurostimulator to vary the stimulating rate. If the detection indicates a state of rest, the neurostimulator rate reduces the patient's heart rate below the patient's normal resting rate. If the detection indicates physical exertion, the neurostimulator rate increases the patient's heart rate above the normal resting rate.Type: GrantFiled: August 21, 2001Date of Patent: September 16, 2003Assignee: Cyberonics, Inc.Inventors: Reese S. Terry, Jr., Robert A. Adkins, Burke T. Barrett
-
Patent number: 6622047Abstract: A method and apparatus for treating patients with neuropsychiatric disorder includes unilaterally or bilaterally stimulating one or both of the left and right branches of a patient's vagus nerve directly or indirectly with an electrical pulse signal generated by an implantable neurostimulator with at least one operatively coupled nerve electrode to apply the pulse signal to the selected nerve branch at a location in the vicinity of the patient's diaphragm, either slightly above or slightly below the diaphragm. The implantable neurostimulator is programmable to enable physician programming of electrical and timing parameters of the pulse signal, to generate the desired therapy regimen for alleviating the disorder. Patient activation of the device is permitted in the case of treating a neuropsychiatric disorder such as depression, where the patient is able to sense a symptom of a disorder.Type: GrantFiled: July 28, 2001Date of Patent: September 16, 2003Assignee: Cyberonics, Inc.Inventors: Burke T. Barrett, Reese S. Terry, Jr.
-
Patent number: 6556868Abstract: Methods of improving memory and learning in humans and animals by vagus nerve stimulation are provided. These methods comprise selecting an appropriate human or animal subject and applying to the subject's vagus nerve an electrical stimulation signal having parameter values effective in modulating the electrical activity of the vagus nerve in a manner so as to modulate the activity of preselected portions of the brain.Type: GrantFiled: January 14, 2002Date of Patent: April 29, 2003Assignee: The Board of Trustees of Southern Illinois UniversityInventors: Dean K. Naritoku, Robert A. Jensen, Ronald A. Browning, Kevin B. Clark, Douglas C. Smith, Reese S. Terry, Jr.
-
Patent number: 6473644Abstract: A method is disclosed for treating patients suffering from heart failure to increase cardiac output. The patient's vagus nerve is electrically stimulated or modulated with a sequence of substantially equally spaced pulses by an implanted neurostimulator, and the frequency of the stimulating pulses is adjusted until the patient's heart rate reaches a target rate within a relatively stable target rate range below the low end of the patient's customary resting heart rate. The frequency of the stimulating pulses is maintained at the frequency which ultimately produced the relatively stable target rate range so as not to deviate markedly from the target rate, at least so long as the patient remains at rest. An activity sensor associated with the implanted neurostimulator detects physical activity of the patient and adjusts the frequency of the stimulating pulses accordingly, to elevate the heart rate during periods of physical activity by the patient.Type: GrantFiled: October 13, 1999Date of Patent: October 29, 2002Assignee: Cyberonics, Inc.Inventors: Reese S. Terry, Jr., Burke Barrett, Alan Adkins
-
Patent number: 6339725Abstract: Methods of modulating brain neural plasticity, improving memory and learning, improving recovery from traumatic brain injury, preventing epilepsy, treating memory disorders and chronic memory impairment, and treating persistent impairment of consciousness in humans and animals by vagus nerve stimulation are provided. These methods comprise selecting an appropriate human or animal subject and applying to the subject's vagus nerve an electrical stimulation signal having parameter values effective in modulating the electrical activity of the vagus nerve in a manner so as to modulate the activity of preselected portions of the brain.Type: GrantFiled: July 10, 2000Date of Patent: January 15, 2002Assignee: The Board of Trustees of Southern Illinois UniversityInventors: Dean K. Naritoku, Robert A. Jensen, Ronald A. Browning, Kevin B. Clark, Douglas C. Smith, Reese S. Terry, Jr.
-
Patent number: 6104956Abstract: Methods of modulating brain neural plasticity, improving memory and learning, improving recovery from traumatic brain injury, preventing epilepsy, treating memory disorders and chronic memory impairment, and treating persistent impairment of consciousness in humans and animals by vagus nerve stimulation are provided. These methods comprise selecting an appropriate human or animal subject and applying to the subject's vagus nerve an electrical stimulation signal having parameter values effective in modulating the electrical activity of the vagus nerve in a manner so as to modulate the activity of preselected portions of the brain.Type: GrantFiled: May 30, 1997Date of Patent: August 15, 2000Assignee: Board of Trustees of Southern Illinois UniversityInventors: Dean K. Naritoku, Robert A. Jensen, Ronald A. Browning, Kevin B. Clark, Douglas C. Smith, Reese S. Terry, Jr.
-
Patent number: 5928272Abstract: A device and method of controlling seizures in an epileptic patient, in which the device is implanted in the patient for selective activation to generate an electrical waveform constituting a pre-programmed therapy regimen for application to the patient's vagus nerve to modulate the electrical activity thereof in a manner to inhibit, abort, or reduce the severity and duration of the seizure. The device is activated to generate the waveform upon detecting a time rate of change in the patient's heart rate relative to a predetermined threshold time rate of change which is sufficiently abrupt and of sufficient magnitude to be inconsistent with normal physical activity, as being indicative of an imminent epileptic seizure. Sustained cardiac activity at the highest heart rate detected in the change in heart rate is used as a confirmation of imminent seizure.Type: GrantFiled: May 2, 1998Date of Patent: July 27, 1999Assignee: Cyberonics, Inc.Inventors: Robert A. Adkins, Cormac A. O'Donovan, Reese S. Terry, Jr.
-
Patent number: 5707400Abstract: A method of treating patients suffering from refractory hypertension includes identifying a patient suffering from the disorder and applying a stimulating electrical signal to the patient's vagus nerve predetermined to modulate the electrical activity of the nerve and to alleviate the hypertension. The step of applying the stimulation may be performed manually by the patient, or automatically following detection of the hypertension by sensing the patient's blood pressure, or, preferably by continuous or periodic application without use of a sensor. The stimulating signal is a pulse waveform with programmable signal parameter values including pulse width, output current, frequency, on time and off time.Type: GrantFiled: September 19, 1995Date of Patent: January 13, 1998Assignee: Cyberonics, Inc.Inventors: Reese S. Terry, Jr., Ross G. Baker, Jr., Andre Marquette
-
Patent number: 5571150Abstract: A method of treating a patient in coma is performed by placing an electrode in juxtaposition with a preselected cranial nerve of the patient for electrical stimulation of the nerve, applying an electrical pulse waveform to the electrode to stimulate the cranial nerve, and adjusting electrical parameters of the pulse waveform to modulate electrical activity of the nerve in an effort to rouse the patient from the coma. The patient's response to the treatment is monitored and assessed by the attending physician according to Glasgow coma scale. The preferred cranial nerve is the vagus nerve, and the stimulation is performed either for acute treatment by positioning an esophageal electrode in the patient for stimulating a region of the vagus nerve in the neck, or for longer term treatment by implanting a nerve electrode on the vagus nerve.Type: GrantFiled: December 19, 1994Date of Patent: November 5, 1996Assignee: Cyberonics, Inc.Inventors: Joachim F. Wernicke, Reese S. Terry, Jr., Ross G. Baker, Jr.
-
Patent number: 5540730Abstract: Apparatus for treating patients with motility disorders applies a modulating signal to the patient's vagus nerve to stimulate or inhibit neural impulses and produce excitatory or inhibitory neurotransmitter release by the vagus nerve according to the specific nature of the motility disorder. The apparatus includes a neurostimulator which can be activated to generate an electrical output signal. The neurostimulator is responsive to the sensing of a selected event having occurred which is indicative of the need for treatment of the motility disorder, and includes an activation element which responds to sensing of that event to activate the neurostimulator, and a lead with an electrode array to apply the electrical output signal as the modulating signal to the patient's vagus nerve. Certain parameters of the output signal are programmable, and the neurostimulator can be calibrated according to the specific patient and the specific motility disorder being treated.Type: GrantFiled: June 6, 1995Date of Patent: July 30, 1996Assignee: Cyberonics, Inc.Inventors: Reese S. Terry, Jr., Ross G. Baker, Jr., Andre Marquette
-
Patent number: 5335657Abstract: Method and apparatus for treating and controlling sleep disorders by detecting the presence of the sleep disorder under treatment, and, in response, selectively applying a predetermined electrical signal to the patient's vagus nerve for stimulation thereof to alleviate the sleep disorder under treatment. The method and apparatus includes several techniques for detecting the presence of the sleep disorder under treatment, such as sensing the patient's EEG activity in the case of insomniac and hypersomniac patients, or detecting a sudden nodding of the head in the case of narcoleptic patients, or sensing the cessation of respiration in the case of sleep apnea patients.Type: GrantFiled: May 3, 1991Date of Patent: August 9, 1994Assignee: Cyberonics, Inc.Inventors: Reese S. Terry, Jr., Joachim F. Wernicke
-
Patent number: 5330515Abstract: Method and apparatus for treating severe chronic, persistent or recurring neuropathic or psychogenic pain, or pain which is nociceptive if the patient is suffering from terminal disease, by selectively applying a pulse waveform to a lead/electrode implanted on the patient's cervical vagus nerve or other site preferably above the location of the pain to stimulate afferent fibers for activating a descending anti-nociceptive pathway and thereby blocking incoming pain signals. The pulse waveform has programmable pulse width, current level and frequency, and pulse sequence on and off time durations. The programmed pulse sequences are applied to the implanted electrode either on a continuous basis, or only during the period the patient is normally awake, or is initiated by the patient or automatically in response to the onset of pain.Type: GrantFiled: June 17, 1992Date of Patent: July 19, 1994Assignee: Cyberonics, Inc.Inventors: Paul Rutecki, Joachim F. Wernicke, Reese S. Terry, Jr.
-
Patent number: 5304206Abstract: Improvements are disclosed in apparatus and techniques for activating an implantable medical device, such as a neurostimulator adapted to treat and control a disorder of a patient where the disorder is susceptible to relief in response to predetermined modulation of the electrical activity of a selected nerve or group of nerves of the patient. The neurostimulator includes a stimulus generator responsive, when activated, to generate a programmable electrical waveform, and an electrode array electrically connected to the stimulus generator for delivering the waveform to a selected nerve of the patient, such as the vagus nerve. The neurostimulator is also adapted to be programmed to provide the waveform with parameter values selected to stimulate the selected nerve to produce the predetermined modulation of the nerve's electrical activity.Type: GrantFiled: November 18, 1991Date of Patent: April 19, 1994Assignee: Cyberonics, Inc.Inventors: Ross G. Baker, Jr., Reese S. Terry, Jr., Alan Adkins
-
Patent number: 5299569Abstract: Method and apparatus for treating and controlling neuropsychiatric disorders including schizophrenia, depression, and borderline personality disorder by selectively applying a predetermined electrical signal to the patient's vagus nerve for stimulation thereof to alleviate the symptoms of the disorder being treated. The electrical signal may be applied continuously, periodically, or intermittently to the vagus nerve depending, in part, on the nature of the disorder being treated. In certain instances, the electrical signal is applied upon detection of an event indicative of onset of the disorder. In other instances, the electrical signal is selectively applied at will to the vagus nerve, such as by patient activation of the signal generator. Parameter values of the electrical signal including pulse width, output current, frequency, on time and off time, are selectively programmable.Type: GrantFiled: May 3, 1991Date of Patent: April 5, 1994Assignee: Cyberonics, Inc.Inventors: Joachim F. Wernicke, Reese S. Terry, Jr., Jacob Zabara